Prognostic significance of maximum tumour (bulk) diameter in young patients with good-prognosis diffuse large-B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: an exploratory analysis of the MabThera International Trial Group (MInT) study
Titel:
Prognostic significance of maximum tumour (bulk) diameter in young patients with good-prognosis diffuse large-B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: an exploratory analysis of the MabThera International Trial Group (MInT) study
Auteur:
Pfreundschuh, Michael Ho, Anthony D Cavallin-Stahl, Eva Wolf, Max Pettengell, Ruth Vasova, Ingrid Belch, Andrew Walewski, Jan Zinzani, Pier-Luigi Mingrone, Walter Kvaloy, Stein Shpilberg, Ofer Jaeger, Ulrich Hansen, Mads Corrado, Claudia Scheliga, Adriana Loeffler, Markus Kuhnt, Evelyn